| Literature DB >> 28573234 |
Arzu Birinci Yildirim1, Birgul Guner1, Fatma Pehlivan Karakas1, Arzu Ucar Turker2.
Abstract
BACKGROUND: Lysimachia vulgaris L. (Yellow loosestrife) is a medicinal plant in the family Myrsinaceae. It has been used in the treatment of fever, ulcer, diarrhea and wounds in folk medicine. It has also analgesic, expectorant, astringent and anti-inflammatory activities. Two different sources of the plant (field-grown and in vitro-grown) were used to evaluate the biological activities (antibacterial, antitumor and antioxidant) of L. vulgaris. In vitro-grown plant materials were collected from L. vulgaris plants that were previously regenerated in our laboratory.Entities:
Keywords: Aluminum chloride colorimetric; DPPH; Folin-Ciocalteau; HPLC; Lysimachia vulgaris; antibacterial; antitumor
Mesh:
Substances:
Year: 2017 PMID: 28573234 PMCID: PMC5446442 DOI: 10.21010/ajtcam.v14i2.19
Source DB: PubMed Journal: Afr J Tradit Complement Altern Med ISSN: 2505-0044
Designation, plant material and yield of extracts.
| Extract | Designation | Part used | Yield |
|---|---|---|---|
| NLW | Field-grown leaves | 12 | |
| NFW | Field-grown flowers | 18 | |
| NAW | Field-grown aerial parts | 59 | |
| IVW | 22 | ||
| SW | Field-grown seeds | 6 | |
| NLE | Field-grown leaves | 9 | |
| NFE | Field-grown flowers | 12 | |
| NAE | Field-grown aerial parts | 7 | |
| IVE | In vitro-grown leaves and stems | 10 | |
| SE | Field-grown seeds | 7 | |
| NLA | Field-grown leaves | 6 | |
| NFA | Field-grown flowers | 12 | |
| NAA | Field-grown aerial parts | 7 | |
| IVA | 10 | ||
| SA | Field-grown seeds | 7 |
Yield (%) = Weight of extract (g) / 20 gr of powdered plant sample * 100
Antibacterial activities of L. vulgaris extracts. Data presented as zone of inhibition of bacterial growth in mm. Means with the same letter within columns are not significantly different at P>0.05
| Mean diameter of inhibitory zones (mm ± SE) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Treatments | ||||||||||
| NLW | 7.4 ± 0.2fg | - | - | - | - | - | - | 7.0 ± 0.0e | - | - |
| NLE | 7.5 ± 0.2fg | 10.7 ± 0.5fg | 9.3 ± 0.2hij | - | - | - 7.9 ± 0.2f | 7.0 ± 0.0e | - | - | |
| NLA | - | 11.4 ± 0.14f | 12.3 ± 0.8g | 7.6 ± 0.3f | - | - | - | - | - | - |
| NFW | 8.4 ± 0.2ef | 7.7 ± 0.1hi | 7.4 ± 0.1j | - | - | - | - | - | - | - |
| NFE | 17.7 ± 0.3d | 19.1 ± 0.4e | 10.9 ± 0.2ghi | 7.6 ± 0.3f | - | - | 9.8 ± 0.4e | 7.4 ± 0.1e | 8.0 ± 0.2e | 8.6 ± 2.0f |
| NFA | - | 8.2 ± 0.1hi | 11.3 ± 0.7g | - | - | - | - | - | - | - |
| NAW | 7.9 ± 0.3fg | 8.8 ± 0.2ghi | 7.8 ± 0.3j | - | - | 7.3 ± 0.1e | - | 8.8 ± 0.1d | - | - |
| NAE | 7.9 ± 0.3fg | 10.0 ± 0.4fgh | 16.1 ± 0.5f | - | - | 7.1 ± 1.0e | - | 9.3 ± 0.1d | - | - |
| NAA | 7.0 ± 0.7g | 7.0 ± 0.0i | 11.1 ± 0.3gh | - | - | - | - | - | - | - |
| IVW | - | - | - | - | - | - | - | - | - | - |
| IVE | - | - | - | - | - | - | - | - | - | - |
| IVA | 9.2 ± 0.12e | 8.6 ± 0.3ghi | 9.1 ± 0.2ij | - | - | - | 7.3 ± 0.1f | - | - | - |
| SW | - | - | - | - | - | - | - | - | - | - |
| SE | 7.0 ± 0.0g | 8.1 ± 0.3hi | 12.8 ± 0.7g | - | - | - | - | - | - | - |
| SA | - | 9.3 ± 0.3%K | 12.4 ± 0.7g | - | - | - | - | - | - | - |
| Ampicillin (10 mg) | 39.2 ± 1.9a | 23.2 ± 4.3d | 48.0 ± 2.6a | 13.4 ± 1.3d | 26.2 ± 0.6b | - | 23.2 ± 2.9c | - | 28.0 ± 1.3d | 21.6 ± 0.9d |
| Carbenicillin (100mg) | 39.6 ± 0.9a | 28.0 ± 4.3c | 44.4 ± 2.5b | 25.2 ± 0.4b | 26.4 ± 2.6b | 21.2 ± 2.8a | 34.4 ± 2.9a | - | 33.0 ± 1.4a | 23.2 ± 0.9c |
| Chloramphenicol (30 mg) | 27.0 ± 1.1c | 32.4 ± 2.8b | 34.0 ± 1.1e | 29.2 ± 1.5a | 28.0 ± 1.1a | 8.6 ± 2.4d | 21.8 ± 1.6d | 28.8 ± 0.8a | 30.8 ± 0.6b | 27.8 ± 0.9b |
| Erythromycin (15 mg) | 26.6 ± 1.4c | 35.0 ± 3.1a | 38.6 ± 1.3d | 9.4 ± 1.6e | 10.8 ± 0.7c | 10.4 ± 1.4c | 10.4 ± 0.8e | 11.8 ± 1.2c | - | 14.0 ± 2.1e |
| Tetracycline (30 mg) | 32.6 ± 1.1b | 9.4 ± 0.3fgh | 42.2 ± 2.4c | 23.6 ± 0.9c | 26.0 ± 1.1b | 17.8 ± 1.2b | 32.6 ± 2. db | 27.4 ± 1.1b | 29.6 ± 1.2c | 29.2 ± 0.6a |
| DMSO | - | - | - | - | - | - | - | - | - | - |
| Water | - | - | - | - | - | - | - | - | - | - |
Mean number of tumors observed with L. vulgaris extracts that dissolved in DMSO at 1000 mg/l and controls (DMSO and camptothecin). Means with the same letter are not significantly different at P>0.05.
| % Inhibition of DPPH Concentrations | ||||
|---|---|---|---|---|
| Treatments | 25 μg/ml | 50 μg/ml | 100 μg/ml | 200 μg/ml |
| 62.35 | 97.01 | 97.21 | 96.91 | |
| 96.3 | 97.2 | 97.6 | 97.7 | |
| 94.7 | 95.6 | 96.7 | 98.1 | |
| 91.3 | 94.6 | 94.9 | 95.9 | |
| 95.3 | 96.5 | 97.1 | 98.5 | |
| 94.0 | 94.4 | 94.8 | 95.1 | |
| 94.4 | 94.9 | 95.2 | 95.8 | |
| 80.5 | 84.7 | 85.2 | 91.3 | |
| 62.8 | 63.7 | 65.7 | 61.7 | |
Mean number of tumors observed with L. vulgaris extracts that dissolves in water at 100.000 mg/l and controls (water and camptothecin). Means with the same letter are not significantly different at P>0.05.
| Treatments | Me an Numbe r of Tumors (± SE) | Tumor Inhibition (%) |
|---|---|---|
| Water (negative control) | 77.1 ± 5.3d | _ |
| Camptothecin (positive control) | 0 | 100 |
| NFW | 0.3 ± 0.1a | 99.6 |
| IVW | 9.4 ± 2.1b | 87.8 |
| IVE | 10.5 ± 1.3b | 86.4 |
| NAW | 11.1 ± 1.6b | 85.6 |
| NLW | 13.3 ± 1.4b | 82.7 |
| NAE | 20.4 ± 2.2c | 73.5 |
| SW | 22.8 ± 1.8c | 70.4 |
| NLE | 26.7 ± 2.3c | 65.4 |
Mean number of tumors observed with L. vulgaris extracts that dissolves in water at 1000 mg/l and controls (water and camptothecin). Means with the same letter are not significantly different at P>0.05.
| Treatments | Mean Number of Tumors (± SE) | Tumor Inhibition (%) |
|---|---|---|
| Water (negative control) | 119.9 ± 6.1e | _ |
| Camptothecin (positive control) | 0 | 100 |
| IVE | 50.0 ± 3.4b | 58.3 |
| IVW | 54.3 ± 4.6bc | 54.7 |
| NAE | 65.3 ± 5.1bcd | 45.5 |
| NFW | 67.4 ± 6.0bcd | 43.8 |
| SW | 72.7 ± 7.8cd | 39.4 |
| NLE | 78.6 ± 4.6d | 34.4 |
| NAW | 84.8 ± 6.8d | 29.3 |
| NLW | 131.8 ± 10.3e | - |
% inhibition of DPPH by L. vulgaris extracts.
| % inhibition of DPPH Concentrations | ||||
|---|---|---|---|---|
| Treatments | 25 μg/ml | 50 μg/ml | 100 μg/ml | 200 μg/ml |
| 62.35 | 97.01 | 97.21 | 96.91 | |
| 96.3 | 97.2 | 97.6 | 97.7 | |
| 94.7 | 95.6 | 96.7 | 98.1 | |
| 91.3 | 94.6 | 94.9 | 95.9 | |
| 95.3 | 96.5 | 97.1 | 98.5 | |
| 94.0 | 94.4 | 94.8 | 95.1 | |
| 94.4 | 94.9 | 95.2 | 95.8 | |
| 80.5 | 84.7 | 85.2 | 91.3 | |
| 62.8 | 63.7 | 65.7 | 61.7 | |
Total phenolic and flavonoid content of L. vulgaris extracts.
| Treatments | Total Phenolics in mg GA/g dry extract | Total Flavonoids in mg CE/g dry extract |
|---|---|---|
| 93.55 ± 0.000 | 96.54 ± 0.00 | |
| 195.36 ± 0.000 | 99.37 ± 0.00 | |
| 62.94 ± 0.00 | 47.14 ± 0.00 | |
| 86.88 ± 0.00 | 64.08 ± 0.00 | |
| 88.69 ± 0.00 | 72.55 ± 0.00 | |
| 161.42 ± 0.00 | 95.13 ± 0.00 | |
| 13.55 ± 0.00 | 27.38 ± 0.00 | |
Figure 1Chromatogram of the selected standards. 1. Gallic acid, 2. Caffeic acid, 3. Rutin hydrate, 4. Luteolin-7-O-β-D glucoside, 5. Kaempferol, 6. Myricetin, 7. Quercetin, 8. Coumarin, 9. Apigenin.
Identified phenolic compounds and their amounts in the methanolic extracts of field-grown and in vitro-grown L. vulgaris.
| STANDART COMPOUNDS | PLANT EXTRACTS (mg/g dry extract) | |||
|---|---|---|---|---|
| Name | Peak number | RT (min) | NLM | ILM |
| Gallic acid monohydrate | 1 | 5.15 | 0.1416 | 0.00562 |
| Caffeic acid | 2 | 11.25 | 0.0747 | 0.19345 |
| Rutin hydrate | 3 | 11.82 | 29.0241 | 0.56243 |
| Luteolin-7-O-β-D glucoside | 4 | 12.3 | 8.9261 | 1.80619 |
| Kaempferol-3β-D-glucopyranoside | 5 | 12.98 | 0.4370 | 0.30864 |
| Myricetin | 6 | 14.4 | 0.4953 | 0.30491 |
| Quercetin | 7 | 16.07 | 1.6796 | 0.04125 |
| Coumarin | 8 | 16.76 | 0.0189 | 0.00478 |
| Apigenin | 9 | 17.29 | 0.4531 | 0.04957 |